Stay updated on Avicanna Press Releases

Sign up to get notified when there's something new on the Avicanna Press Releases page.
Latest website image capture
Clouds background image

Latest updates to the Avicanna Press Releases page

  1. Check
    yesterday
    Change Detected
    Summary
    The webpage has been updated to reflect the announcement of Avicanna's Annual General Meeting results on June 30, 2025, replacing the previous announcement dated April 14, 2025, which included the company's full year 2024 results.
    Difference
    7%
    Check dated 2025-07-05T02:28:23.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    Avicanna has announced significant updates, including the sponsorship of a clinical study for osteoarthritis pain and reporting its first profitable quarter for Q1 2025. Additionally, the company has had a Management Cease Trade Order revoked.
    Difference
    7%
    Check dated 2025-06-20T17:52:39.000Z thumbnail image
  4. Check
    22 days ago
    No Change Detected
  5. Check
    30 days ago
    No Change Detected
  6. Check
    66 days ago
    Change Detected
    Summary
    Avicanna has announced the revocation of a management cease trade order, which is a significant update regarding the company's regulatory status.
    Difference
    6%
    Check dated 2025-05-01T06:03:47.000Z thumbnail image
  7. Check
    80 days ago
    Change Detected
    Summary
    The page has been updated to include Avicanna's full year 2024 audited financial statement, while a previous announcement regarding a management cease trade order has been removed.
    Difference
    7%
    Check dated 2025-04-16T16:39:39.000Z thumbnail image
  8. Check
    88 days ago
    Change Detected
    Summary
    The Ontario Securities Commission has approved Avicanna's application for a management cease trade order, and the company has announced its 5th Medical Symposium on Cannabinoid-based Medicine, both dated April 7, 2025.
    Difference
    8%
    Check dated 2025-04-09T11:18:05.000Z thumbnail image
  9. Check
    95 days ago
    Change Detected
    Summary
    Avicanna has announced a full-year earnings conference call and a collaboration with Vectura Fertin Pharma, while previous reports on the completion of product deliveries and Q3 2024 results have been removed.
    Difference
    1%
    Check dated 2025-04-01T23:52:19.000Z thumbnail image

Stay in the know with updates to Avicanna Press Releases

Enter your email address, and we'll notify you when there's something new on the Avicanna Press Releases page.